
US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
Description
US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
The U.S. medical diagnostics market is anticipated to reach US$43.89 billion in 2028, witnessing growth at a CAGR of 4.62%, over the period 2024-2028. The factors such as increasing geriatric population, growing burden of chronic diseases, escalating penetration of electronic health record (EHR) systems, hike in healthcare expenditure and expanding urbanization would drive the growth of the market. However, the market growth would be challenged by dearth of trained laboratory technicians, high cost of high end molecular diagnostics and in vitro diagnostics devices and challenging premarket approval (PMA) & IVD labelling requirements. A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.
The U.S. medical diagnostics market has been segmented on the basis of type, product type and end-users. In terms of type, the market can be bifurcated into in-vitro diagnostics and in-vivo diagnostics. The U.S. in-vitro diagnostics market is further divided on the basis of product type and application. Depending on the product type, the U.S. medical diagnostics market can be segmented into reagents, instruments and software & services. Whereas, the market can be split into hospitals, diagnostic centers and Physician Office Labs (POLs) & others, on the basis of end-users.
The fastest growing regional market was Southern U.S., owing to the rising susceptibility of the population to various chronic and infectious diseases, growing adoption of automation in reference laboratories and hospitals, increasing patient awareness about personalized medicine and shifting preference towards point-of-care (POC) testing.
Scope of the report:
- The report provides a comprehensive analysis of the U.S. medical diagnostics market segmented on the basis of type, product type, end users and region.
- The major regional and country markets (Southern, Mid-Western, Western and North Eastern U.S.) have been analyzed.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., and BioMerieux SA) are also presented in detail.
- Diagnostic Service Providers
- Diagnostic Products Manufacturers and Distributors of IVD Products
- Hospitals, Public Labs, Diagnostic Centers and Other Stakeholders
- Organizations, Forums and Alliances related to Medical Diagnostics
- Government Bodies & Regulating Authorities
Table of Contents
73 Pages
- 1. Market Overview
- 1.1 Introduction
- Table 1: Process of Medical Diagnosis
- 1.2 Types of Diagnostics
- Table 2: Types of Diagnostics
- 1.3 General Components of a Diagnostic Procedure
- Table 3: General Components of a Diagnostic Procedure
- 1.4 Anatomy of a Diagnostic Test
- Table 4: Anatomy of a Diagnostic Test
- 1.5 Categories of Diagnostic Tests
- Table 5: Categories of Diagnostic Tests
- 1.6 Major Roles of Diagnostic Testing
- Table 6: Major Roles of Diagnostic Testing
- 1.7 Sources of Medical Information for Diagnosis
- Table 7: Sources of Medical Information for Diagnosis
- 1.8 Common Types of Diagnostic Tools
- Table 8: Common Types of Diagnostic Tools
- 2. Impact of COVID-19
- 2.1 Demand Surge for Medical Diagnostics
- Table 9: Number of COVID-19 Tests Performed Daily in the U.S. (March - November 2020)
- 2.2 Growth in Government Spending on Healthcare
- Table 10: The U.S. National Health Expenditure as Percent of GDP (2016-2020)
- 2.3 Surging Adoption of Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
- Table 11: Molecular Assays Performed per Week in the U.S. (March-October 2020)
- 3. The U.S. Market Analysis
- 3.1 The U.S. Medical Diagnostics Market by Value
- Table 12: The U.S. Medical Diagnostics Market by Value (2019-2023)
- 3.2 The U.S. Medical Diagnostics Market Forecast by Value
- Table 13: The U.S. Medical Diagnostics Market Forecast by Value (2024-2028)
- 3.3 The U.S. Medical Diagnostics Market by Type
- Table 14: The U.S. Medical Diagnostics Market by Type (2023)
- 3.3.1 The U.S. In-Vitro Diagnostics Market by Value
- Table 15: The U.S. In-Vitro Diagnostics Market by Value (2019-2023)
- 3.3.2 The U.S. In-Vitro Diagnostics Market Forecast by Value
- Table 16: The U.S. In-Vitro Diagnostics Market Forecast by Value (2024-2028)
- 3.3.3 The U.S. In-Vitro Diagnostics Market by Product Type
- Table 17: The U.S. In-Vitro Diagnostics Market by Product Type (2023)
- 3.3.4 The U.S. In-Vitro Diagnostics Product Type Market by Value
- Table 18: The U.S. Medical Diagnostics Application Market by Value (2019-2023)
- 3.3.5 The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value
- Table 19: The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value (2024-2028)
- 3.3.6 The U.S. In-Vitro Diagnostics Market by Application
- Table 20: The U.S. In-Vitro Diagnostics Market by Application (2023)
- 3.3.7 The U.S. In-Vitro Diagnostics Application Market Forecast by Value
- Table 21: The U.S. In-Vitro Diagnostics Application Market Forecast by Value (2023-2028)
- 3.3.8 The U.S. In-Vivo Diagnostics Market by Value
- Table 22: The U.S. In-Vivo Diagnostics Market by Value (2019-2023)
- 3.3.9 The U.S. In-Vivo Diagnostics Market Forecast by Value
- Table 23: The U.S. In-Vivo Diagnostics Market Forecast by Value (2024-2028)
- 3.4 The U.S. Medical Diagnostics Market by Product Type
- Table 24: The U.S. Medical Diagnostics Market by Product Type (2023)
- 3.4.1 The U.S. Medical Diagnostics Product Type Market by Value
- Table 25: The U.S. Medical Diagnostics Product Type Market by Value (2019-2023)
- 3.4.2 The U.S. Medical Diagnostics Product Type Market Forecast by Value
- Table 26: The U.S. Medical Diagnostics Product Type Market Forecast by Value (2024-2028)
- 3.5 The U.S. Medical Diagnostics Market by End-Users
- Table 27: The U.S. Medical Diagnostics Market by End-Users (2023)
- 3.5.1 The U.S. Medical Diagnostics End-User Market by Value
- Table 28: The U.S. Medical Diagnostics End-User Market by Value (2019-2023)
- 3.5.2 The U.S. Medical Diagnostics End-User Market Forecast by Value
- Table 29: The U.S. Medical Diagnostics End-User Market Forecast by Value (2024-2028)
- 3.6 The U.S. Medical Diagnostics Market by Region
- Table 30: The U.S. Medical Diagnostics Market by Region (2023)
- 4. Regional Market Analysis
- 4.1 Southern U.S.
- 4.1.1 Southern U.S. Medical Diagnostics Market Forecast by Value
- Table 31: Southern U.S. Medical Diagnostics Market Forecast by Value (2023-2028)
- 4.2 Mid-Western U.S.
- 4.2.1 Mid-Western U.S. Medical Diagnostics Market Forecast by Value
- Table 32: Mid-Western U.S. Medical Diagnostics Market Forecast by Value (2023-2028)
- 4.3 Western U.S.
- 4.3.1 Western U.S. Medical Diagnostics Market Forecast by Value
- Table 33: Western U.S. Medical Diagnostics Market Forecast by Value (2023-2028)
- 4.4 North Eastern U.S.
- 4.4.1 North Eastern U.S. Medical Diagnostics Market Forecast by Value
- Table 34: North Eastern U.S. Medical Diagnostics Market Forecast by Value (2023-2028)
- 5. Market Dynamics
- 5.1 Growth Drivers
- 5.1.1 Increasing Geriatric Population
- Table 35: The U.S. Population 65 Years and Older (2015-2060)
- 5.1.2 Growing Burden of Chronic Diseases
- Table 36: Number of People with Chronic Conditions in the U.S. (2010-2030)
- 5.1.3 Escalating Penetration of Electronic Health Record (EHR) Systems
- Table 37: Penetration Forecast of Electronic Health Record (EHR) Systems in the U.S. (2018-2024)
- 5.1.4 Hike in Healthcare Expenditure
- Table 38: The U.S. National Healthcare Expenditure Forecast (2021-2028)
- 5.1.5 Expanding Urbanization
- Table 39: Degree of Urbanization in the U.S. (2015-2030)
- 5.2 Key Trends and Developments
- 5.2.1 Surging Adoption of Healthcare-related Devices Like Wearables
- Table 40: Number of Wearable Device Users in the U.S. (2017-2023)
- 5.2.2 Emergence of Various Pandemic Diseases
- Table 41: Brief History of Pandemics
- 5.2.3 Rising Integration with Artificial Intelligence
- Table 42: Artificial Intelligence In Diagnostics Market in the U.S. (2020-2026)
- 5.2.4 Growing Awareness on Personalized Medicine
- 5.3 Challenges
- 5.3.1 Dearth of Trained Laboratory Technicians
- 5.3.2 High Cost of High-end Molecular Diagnostics & In-Vitro Diagnostics Devices
- 5.3.3 Challenging Premarket Approval (PMA) & IVD Labelling Requirements
- 6. Company Profiles
- 6.1 Roche Holding AG
- 6.1.1 Business Overview
- 6.2 Abbott Laboratories
- 6.2.1 Business Overview
- 6.3 Danaher Corporation
- 6.3.1 Business Overview
- 6.4 Becton, Dickinson and Company
- 6.4.1 Business Overview
- 6.5 Quest Diagnostics Inc.
- 6.5.1 Business Overview
- 6.6 BioMerieux SA
- 6.6.1 Business Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.